Likewise, OSO2% efficiently curtailed CML-induced IL-6 and ROS generation, indicating OSO’s anti-inflammatory and antioxidant role (Figure 9). The gene discussed is IL6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.